Nancy C Brahm

Summary

Affiliation: University of Oklahoma Health Sciences Center
Country: USA

Publications

  1. doi Commonly prescribed medications and potential false-positive urine drug screens
    Nancy C Brahm
    Department of Pharmacy Practice, Clinical and Administrative Sciences, College of Pharmacy, University of Oklahoma, 4502 East 41st Street, Tulsa, OK 74135 2512, USA
    Am J Health Syst Pharm 67:1344-50. 2010
  2. doi Case report: increased patient response to intramuscular haloperidol decanoate following a change in needle length
    Nancy C Brahm
    College of Pharmacy, University of Oklahoma, Tulsa, OK 74135 2512, USA
    J Pharm Pract 24:561-3. 2011
  3. ncbi Quetiapine for acute mania in bipolar disorder
    Nancy C Brahm
    Department of Pharmacy Clinical and Administrative Sciences, University of Oklahoma College of Pharmacy UOCP, Tulsa, OK 74135 2512, USA
    Am J Health Syst Pharm 64:1045-53. 2007
  4. ncbi Clinical pharmacology services: a pharmacist-based consulting service for the developmentally disabled
    Nancy C Brahm
    Clinical Pharmacology Services, Developmental Disabilities Services Department, College of Pharmacy, University of Oklahoma, Oklahoma City 73117 1223, USA
    Am J Health Syst Pharm 61:487-93. 2004
  5. ncbi Risperidone for the treatment of fecal smearing in a developmentally disabled adult
    Nancy C Brahm
    Department of Pharmacy Practice, University of Oklahom, Tulsa, OK 74135 2512, USA
    Am J Health Syst Pharm 64:382-4. 2007
  6. ncbi Potential aripiprazole-mediated extrapyramidal symptoms in an adult with developmental disabilities
    Nancy C Brahm
    Department of Pharmacy Clinical and Administrative Sciences, College of Pharmacy, University of Oklahoma UO, Tulsa 74135 2512, USA
    Am J Health Syst Pharm 64:827-9. 2007
  7. ncbi Bedlam Community Health Clinic: a collaborative interdisciplinary health care service for the medically indigent
    Nancy C Brahm
    Clinical Pharmacology Services Developmental Disabilities Service Division, College of Pharmacy, University of Oklahoma, Tulsa, OK 74135 2512, USA
    J Am Pharm Assoc (2003) 47:398-403. 2007
  8. ncbi Buspirone for autistic disorder in a woman with an intellectual disability
    Nancy C Brahm
    Department of Pharmacy, College of Pharmacy, University of Oklahoma, Tulsa, OK 74135, USA
    Ann Pharmacother 42:131-7. 2008
  9. doi Probable quetiapine-mediated prolongation of the QT interval
    Nasim Aghaienia
    Department of Pharmacy Practice, Clinical and Administrative Sciences Tulsa, University of Oklahoma College of Pharmacy, Tulsa, OK 74135, USA
    J Pharm Pract 24:506-12. 2011
  10. doi Mental health treatment associated with community-based depression screening: considerations for planning multidisciplinary collaborative care
    Bruce R Winchester
    College of Pharmacy, The University of Oklahoma, Tulsa, OK, USA
    Ann Pharmacother 47:797-804. 2013

Collaborators

Detail Information

Publications13

  1. doi Commonly prescribed medications and potential false-positive urine drug screens
    Nancy C Brahm
    Department of Pharmacy Practice, Clinical and Administrative Sciences, College of Pharmacy, University of Oklahoma, 4502 East 41st Street, Tulsa, OK 74135 2512, USA
    Am J Health Syst Pharm 67:1344-50. 2010
    ..The implications of potential false-positive urine drug screen (UDS) results for patients receiving commonly prescribed medications were evaluated...
  2. doi Case report: increased patient response to intramuscular haloperidol decanoate following a change in needle length
    Nancy C Brahm
    College of Pharmacy, University of Oklahoma, Tulsa, OK 74135 2512, USA
    J Pharm Pract 24:561-3. 2011
    ..Determining the optimum needle length for administration of IM formulations based on individual patient variables has not been extensively reported in patients receiving antipsychotic medication via IM administration...
  3. ncbi Quetiapine for acute mania in bipolar disorder
    Nancy C Brahm
    Department of Pharmacy Clinical and Administrative Sciences, University of Oklahoma College of Pharmacy UOCP, Tulsa, OK 74135 2512, USA
    Am J Health Syst Pharm 64:1045-53. 2007
    ..The efficacy and tolerability of quetiapine in the treatment of acute mania were reviewed...
  4. ncbi Clinical pharmacology services: a pharmacist-based consulting service for the developmentally disabled
    Nancy C Brahm
    Clinical Pharmacology Services, Developmental Disabilities Services Department, College of Pharmacy, University of Oklahoma, Oklahoma City 73117 1223, USA
    Am J Health Syst Pharm 61:487-93. 2004
  5. ncbi Risperidone for the treatment of fecal smearing in a developmentally disabled adult
    Nancy C Brahm
    Department of Pharmacy Practice, University of Oklahom, Tulsa, OK 74135 2512, USA
    Am J Health Syst Pharm 64:382-4. 2007
    ..The use of risperidone in decreasing fecal smearing behavior as an expression of nonverbal aggression in a developmentally disabled adult is discussed...
  6. ncbi Potential aripiprazole-mediated extrapyramidal symptoms in an adult with developmental disabilities
    Nancy C Brahm
    Department of Pharmacy Clinical and Administrative Sciences, College of Pharmacy, University of Oklahoma UO, Tulsa 74135 2512, USA
    Am J Health Syst Pharm 64:827-9. 2007
    ..A case of extrapyramidal symptoms (EPS) following administration of aripiprazole to a man with developmental disabilities who had never received antipsychotic medications and had no history of movement disorders is presented...
  7. ncbi Bedlam Community Health Clinic: a collaborative interdisciplinary health care service for the medically indigent
    Nancy C Brahm
    Clinical Pharmacology Services Developmental Disabilities Service Division, College of Pharmacy, University of Oklahoma, Tulsa, OK 74135 2512, USA
    J Am Pharm Assoc (2003) 47:398-403. 2007
    ..To describe a collaborative interdisciplinary health care service delivery system for the medically indigent in the Tulsa and northeastern Oklahoma area independent of state or federal funding...
  8. ncbi Buspirone for autistic disorder in a woman with an intellectual disability
    Nancy C Brahm
    Department of Pharmacy, College of Pharmacy, University of Oklahoma, Tulsa, OK 74135, USA
    Ann Pharmacother 42:131-7. 2008
    ....
  9. doi Probable quetiapine-mediated prolongation of the QT interval
    Nasim Aghaienia
    Department of Pharmacy Practice, Clinical and Administrative Sciences Tulsa, University of Oklahoma College of Pharmacy, Tulsa, OK 74135, USA
    J Pharm Pract 24:506-12. 2011
    ..Quetiapine, an SGA, was a component of the pharmacotherapy regimen. Based on the Naranjo adverse drug reaction probability scale rating criteria, a probable causal association was made...
  10. doi Mental health treatment associated with community-based depression screening: considerations for planning multidisciplinary collaborative care
    Bruce R Winchester
    College of Pharmacy, The University of Oklahoma, Tulsa, OK, USA
    Ann Pharmacother 47:797-804. 2013
    ..Routine screening has been recognized as a fundamental step in the effective treatment of depression, but should be undertaken only when support systems are available to ensure proper diagnosis, treatment, and follow-up...
  11. ncbi Thyroid function alterations following quetiapine initiation in a developmentally disabled adolescent
    Richard L Dobbs
    Ann Pharmacother 38:1541-2. 2004
  12. ncbi Protozoal infections in the developmentally disabled: often overlooked cause of rectal digging and fecal smearing
    Nancy C Brahm
    Ann Pharmacother 38:1542. 2004
  13. ncbi Assessment of QTc prolongation following thioridazine withdrawal in a developmentally disabled population
    Nancy C Brahm
    J Clin Psychopharmacol 23:314-5. 2003